TY - JOUR
T1 - TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
AU - NYGC ALS Consortium
AU - Brown, Anna Leigh
AU - Wilkins, Oscar G.
AU - Keuss, Matthew J.
AU - Hill, Sarah E.
AU - Zanovello, Matteo
AU - Lee, Weaverly Colleen
AU - Bampton, Alexander
AU - Lee, Flora C.Y.
AU - Masino, Laura
AU - Qi, Yue A.
AU - Bryce-Smith, Sam
AU - Gatt, Ariana
AU - Hallegger, Martina
AU - Fagegaltier, Delphine
AU - Phatnani, Hemali
AU - Phatnani, Hemali
AU - Kwan, Justin
AU - Sareen, Dhruv
AU - Broach, James R.
AU - Simmons, Zachary
AU - Arcila-Londono, Ximena
AU - Lee, Edward B.
AU - Van Deerlin, Vivianna M.
AU - Shneider, Neil A.
AU - Fraenkel, Ernest
AU - Ostrow, Lyle W.
AU - Baas, Frank
AU - Zaitlen, Noah
AU - Berry, James D.
AU - Malaspina, Andrea
AU - Fratta, Pietro
AU - Cox, Gregory A.
AU - Thompson, Leslie M.
AU - Finkbeiner, Steve
AU - Dardiotis, Efthimios
AU - Miller, Timothy M.
AU - Chandran, Siddharthan
AU - Pal, Suvankar
AU - Hornstein, Eran
AU - MacGowan, Daniel J.
AU - Heiman-Patterson, Terry
AU - Hammell, Molly G.
AU - Patsopoulos, Nikolaos A.
AU - Butovsky, Oleg
AU - Dubnau, Joshua
AU - Nath, Avindra
AU - Bowser, Robert
AU - Harms, Matthew
AU - Aronica, Eleonora
AU - Poss, Mary
AU - Phillips-Cremins, Jennifer
AU - Crary, John
AU - Atassi, Nazem
AU - Lange, Dale J.
AU - Adams, Darius J.
AU - Stefanis, Leonidas
AU - Gotkine, Marc
AU - Baloh, Robert H.
AU - Babu, Suma
AU - Raj, Towfique
AU - Paganoni, Sabrina
AU - Shalem, Ophir
AU - Smith, Colin
AU - Zhang, Bin
AU - Harris, Brent
AU - Broce, Iris
AU - Drory, Vivian
AU - Ravits, John
AU - McMillan, Corey
AU - Menon, Vilas
AU - Wu, Lani
AU - Altschuler, Steven
AU - Lerner, Yossef
AU - Sattler, Rita
AU - Van Keuren-Jensen, Kendall
AU - Rozenblatt-Rosen, Orit
AU - Lindblad-Toh, Kerstin
AU - Nicholson, Katharine
AU - Gregersen, Peter
AU - Lee, Jeong Ho
AU - Kokos, Sulev
AU - Muljo, Stephen
AU - Newcombe, Jia
AU - Gustavsson, Emil K.
AU - Seddighi, Sahba
AU - Reyes, Joel F.
AU - Coon, Steven L.
AU - Ramos, Daniel
AU - Schiavo, Giampietro
AU - Fisher, Elizabeth M.C.
AU - Raj, Towfique
AU - Secrier, Maria
AU - Lashley, Tammaryn
AU - Ule, Jernej
AU - Buratti, Emanuele
AU - Humphrey, Jack
AU - Ward, Michael E.
AU - Fratta, Pietro
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/3/3
Y1 - 2022/3/3
N2 - Variants of UNC13A, a critical gene for synapse function, increase the risk of amyotrophic lateral sclerosis and frontotemporal dementia1–3, two related neurodegenerative diseases defined by mislocalization of the RNA-binding protein TDP-434,5. Here we show that TDP-43 depletion induces robust inclusion of a cryptic exon in UNC13A, resulting in nonsense-mediated decay and loss of UNC13A protein. Two common intronic UNC13A polymorphisms strongly associated with amyotrophic lateral sclerosis and frontotemporal dementia risk overlap with TDP-43 binding sites. These polymorphisms potentiate cryptic exon inclusion, both in cultured cells and in brains and spinal cords from patients with these conditions. Our findings, which demonstrate a genetic link between loss of nuclear TDP-43 function and disease, reveal the mechanism by which UNC13A variants exacerbate the effects of decreased TDP-43 function. They further provide a promising therapeutic target for TDP-43 proteinopathies.
AB - Variants of UNC13A, a critical gene for synapse function, increase the risk of amyotrophic lateral sclerosis and frontotemporal dementia1–3, two related neurodegenerative diseases defined by mislocalization of the RNA-binding protein TDP-434,5. Here we show that TDP-43 depletion induces robust inclusion of a cryptic exon in UNC13A, resulting in nonsense-mediated decay and loss of UNC13A protein. Two common intronic UNC13A polymorphisms strongly associated with amyotrophic lateral sclerosis and frontotemporal dementia risk overlap with TDP-43 binding sites. These polymorphisms potentiate cryptic exon inclusion, both in cultured cells and in brains and spinal cords from patients with these conditions. Our findings, which demonstrate a genetic link between loss of nuclear TDP-43 function and disease, reveal the mechanism by which UNC13A variants exacerbate the effects of decreased TDP-43 function. They further provide a promising therapeutic target for TDP-43 proteinopathies.
UR - http://www.scopus.com/inward/record.url?scp=85125039190&partnerID=8YFLogxK
U2 - 10.1038/s41586-022-04436-3
DO - 10.1038/s41586-022-04436-3
M3 - Article
C2 - 35197628
AN - SCOPUS:85125039190
SN - 0028-0836
VL - 603
SP - 131
EP - 137
JO - Nature
JF - Nature
IS - 7899
ER -